The course of mycosis fungoides (MF) is indolent except when transformation to a large T-cell lymphoma occurs. The diagnosis of transformed MF relies on the presence of more than 25% of large cells on biopsy of an MF lesion. Treatment of transformed MF is a major challenge as these patients have poor outcome. Here, we report a 61-year-old man presenting with tumoral ulcer on the plantar area of the foot who was diagnosed cutaneous CD30(−) large cell transformed MF and treated with systemic methotraxate and bexarotene therapy.
ArulogunSOPrinceHMNgJ. Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation. Blood. 2008;112:3082-3087.
2.
SalhanyKECousarJBGreerJPCaseyTTFieldsJPCollinsRD. Transformation of cutaneous T cell lymphoma to large cell lymphoma: a clinicopathologic and immunologic study. Am J Pathol. 1988;132:265-277.
3.
DiamandidouEColome-GrimmerMFayadLDuvicMKurzrockR. Transformation of mycosisfungoides/Sezary syndrome: clinical characteristics and prognosis. Blood. 1998;92:1150-1159.
4.
VergierBde MuretABeylot-BarryM. Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneous Lymphomas. Blood. 2000;95:2212-2218.
5.
WollinaUAbdel NaserMBHanseG. Leg ulcers are a diagnostic and therapeutic challenge. Int J Low Extrem Wounds. 2005;4:97-104.
6.
ZackheimHSKashani-SabetMMcMillanA. Low-dose methotrexate to treat mycosis fungoides: a retrospective study in 69 patientsJ Am Acad Dermatol. 2003;49:873-878.
7.
ZhangCHazarikaPNiXWeidnerDADuvicM. Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. Clin Cancer Res. 2002;8:1234-1240.
8.
KannangaraAPLevitanDFleischerABJr. Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma. J Dermatolog Treat. 2009;20:169-176.
